Transferrin

"Transferrin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An iron-binding beta1-globulin that is synthesized in the LIVER and secreted into the blood. It plays a central role in the transport of IRON throughout the circulation. A variety of transferrin isoforms exist in humans, including some that are considered markers for specific disease states.

Descriptor ID	D014168
MeSH Number(s)	D12.776.124.050.800 D12.776.124.790.223.839 D12.776.157.427.750.500 D12.776.377.715.182.839 D12.776.556.579.750.500
Concept/Terms	Transferrin Transferrin Serotransferrin Siderophilin beta-1 Metal-Binding Globulin Globulin, beta-1 Metal-Binding Metal-Binding Globulin, beta-1 beta 1 Metal Binding Globulin Isotransferrin Isotransferrin Transferrin C Transferrin C tau-Transferrin tau-Transferrin tau Transferrin Transferrin B Transferrin B beta 2-Transferrin beta 2-Transferrin beta 2 Transferrin Monoferric Transferrins Monoferric Transferrins Transferrins, Monoferric

Below are MeSH descriptors whose meaning is more general than "Transferrin".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Blood Proteins [D12.776.124]
Acute-Phase Proteins [D12.776.124.050]
Transferrin [D12.776.124.050.800]
Serum Globulins [D12.776.124.790]
Beta-Globulins [D12.776.124.790.223]
Transferrin [D12.776.124.790.223.839]
Carrier Proteins [D12.776.157]
Iron-Binding Proteins [D12.776.157.427]
Transferrins [D12.776.157.427.750]
Transferrin [D12.776.157.427.750.500]
Globulins [D12.776.377]
Serum Globulins [D12.776.377.715]
Beta-Globulins [D12.776.377.715.182]
Transferrin [D12.776.377.715.182.839]
Metalloproteins [D12.776.556]
Iron-Binding Proteins [D12.776.556.579]
Transferrins [D12.776.556.579.750]
Transferrin [D12.776.556.579.750.500]

Below are MeSH descriptors whose meaning is more specific than "Transferrin".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Transferrin" by people in this website by year, and whether "Transferrin" was a major or minor topic of these publications.

Bar chart showing 52 publications over 22 distinct years, with a maximum of 6 publications in 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1997	0	1	1
2001	2	1	3
2002	1	1	2
2003	1	1	2
2004	1	2	3
2005	1	1	2
2006	0	2	2
2007	1	1	2
2008	1	0	1
2009	4	1	5
2010	2	0	2
2011	1	2	3
2012	2	2	4
2013	4	2	6
2014	0	1	1
2015	4	1	5
2016	0	1	1
2017	1	0	1
2018	2	0	2
2019	1	0	1
2020	0	2	2

Below are the most recent publications written about "Transferrin" by people in Profiles.

Ng BG, Eklund EA, Shiryaev SA, Dong YY, Abbott MA, Asteggiano C, Bamshad MJ, Barr E, Bernstein JA, Chelakkadan S, Christodoulou J, Chung WK, Ciliberto MA, Cousin J, Gardiner F, Ghosh S, Graf WD, Grunewald S, Hammond K, Hauser NS, Hoganson GE, Houck KM, Kohler JN, Morava E, Larson AA, Liu P, Madathil S, McCormack C, Meeks NJL, Miller R, Monaghan KG, Nickerson DA, Palculict TB, Papazoglu GM, Pletcher BA, Scheffer IE, Schenone AB, Schnur RE, Si Y, Rowe LJ, Serrano Russi AH, Russo RS, Thabet F, Tuite A, Villanueva MM, Wang RY, Webster RI, Wilson D, Zalan A, Wolfe LA, Rosenfeld JA, Rhodes L, Freeze HH. Predominant and novel de novo variants in 29 individuals with ALG13 deficiency: Clinical description, biomarker status, biochemical analysis, and treatment suggestions. J Inherit Metab Dis. 2020 11; 43(6):1333-1348.

View in: PubMed
Ambrosy AP, Fitzpatrick JK, Tabada GH, Gurwitz JH, Artz A, Schrier SL, Rao SV, Reynolds K, Smith DH, Peterson PN, Fortmann SP, Sung SH, Cohen HJ, Go AS. A reduced transferrin saturation is independently associated with excess morbidity and mortality in older adults with heart failure and incident anemia. Int J Cardiol. 2020 06 15; 309:95-99.

View in: PubMed
Ren C, Bobst CE, Kaltashov IA. Exploiting His-Tags for Absolute Quantitation of Exogenous Recombinant Proteins in Biological Matrices: Ruthenium as a Protein Tracer. Anal Chem. 2019 06 04; 91(11):7189-7198.

View in: PubMed
Pratt R, Handelman GJ, Edwards TE, Gupta A. Ferric pyrophosphate citrate: interactions with transferrin. Biometals. 2018 12; 31(6):1081-1089.

View in: PubMed
Jadia R, Kydd J, Rai P. Remotely Phototriggered, Transferrin-Targeted Polymeric Nanoparticles for the Treatment of Breast Cancer. Photochem Photobiol. 2018 07; 94(4):765-774.

View in: PubMed
Zhao Y, Peng J, Li J, Huang L, Yang J, Huang K, Li H, Jiang N, Zheng S, Zhang X, Niu Y, Han G. Tumor-Targeted and Clearable Human Protein-Based MRI Nanoprobes. Nano Lett. 2017 07 12; 17(7):4096-4100.

View in: PubMed
Ly S, Navaroli DM, Didiot MC, Cardia J, Pandarinathan L, Alterman JF, Fogarty K, Standley C, Lifshitz LM, Bellve KD, Prot M, Echeverria D, Corvera S, Khvorova A. Visualization of self-delivering hydrophobically modified siRNA cellular internalization. Nucleic Acids Res. 2017 01 09; 45(1):15-25.

View in: PubMed
Pawlowski JW, Kellicker N, Bobst CE, Kaltashov IA. Assessing the iron delivery efficacy of transferrin in clinical samples by native electrospray ionization mass spectrometry. Analyst. 2016 Feb 07; 141(3):853-61.

View in: PubMed
Schonberg DL, Miller TE, Wu Q, Flavahan WA, Das NK, Hale JS, Hubert CG, Mack SC, Jarrar AM, Karl RT, Rosager AM, Nixon AM, Tesar PJ, Hamerlik P, Kristensen BW, Horbinski C, Connor JR, Fox PL, Lathia JD, Rich JN. Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells. Cancer Cell. 2015 Oct 12; 28(4):441-455.

View in: PubMed
Zhao H, Wang S, Nguyen SN, Elci SG, Kaltashov IA. Evaluation of Nonferrous Metals as Potential In Vivo Tracers of Transferrin-Based Therapeutics. J Am Soc Mass Spectrom. 2016 Feb; 27(2):211-9.

View in: PubMed

People

Explore

Similar Concepts

Top Journals